Zeidan, Amer M. http://orcid.org/0000-0001-7017-8160
Pollyea, Daniel A.
Borate, Uma
Vasconcelos, Alberto
Potluri, Ravi
Rotter, David
Kiendrebeogo, Zephirin
Gaugler, Lona
Prebet, Thomas
Strocchia, Maria
Bonifacio, Gaetano
Chen, Clara
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 17 October 2022
Accepted: 23 January 2023
First Online: 3 February 2023
Change Date: 21 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00277-023-05327-x
Declarations
:
: This article contains study data derived from the Flatiron Health longitudinal EHR-derived database. The databases used in the study are de-identified and compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). This article does not contain any studies with human participants or animals performed by any of the authors.
: AMZ has worked in a consulting/advisory role for, received honoraria from, and provided expert testimony for AbbVie, Acceleron, Agios, Amgen, Aprea, Astellas, BeyondSpring, Boehringer Ingelheim, Bristol Myers Squibb, Cardiff Oncology, Cardinal Health, Celgene, Daiichi Sankyo, Epizyme, Geron, Gilead, Incyte, Ionis, Janssen, Jazz, Kura, Novartis, Otsuka, Pfizer, Seattle Genetics, Syndax, Taiho, Takeda, Trovagene, and TYME; has received travel/accommodations/expenses support from Cardiff Oncology, Novartis, and Pfizer; has provided leadership or fiduciary role in other board, society, committee or advocacy group for AbbVie, Bristol Myers Squibb, Celgene, Geron, Gilead, Kura, and Novartis; and has received research/grant support from AbbVie, ADC Therapeutics, Amgen, Aprea, Astex, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Cardiff Oncology, Celgene, Incyte, MedImmune, Novartis, Otsuka, Pfizer, Takeda, and Trovagene. DAP has received research/grant support from AbbVie and has worked in a consulting/advisory role for AbbVie and Genentech. UB has participated in a data safety monitoring or advisory board for AbbVie, Agios, Astellas Takeda, Blueprint, Kura, Novartis, and Servier; has received honoraria from RUNXI Foundation; and has received research support from AbbVie, Incyte, and Jazz. AV and LG are employees of Bristol Myers Squibb. RP, DR, and ZK are employed by SmartAnalyst, which received support from BMS for conducting this study. TP, CC, MS, and GB are employees of and hold stock in Bristol Myers Squibb.